Wikidata

(Q40465362)

English

TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.

scientific article published on January 2005

In more languages
default for all languages
No label defined

No description defined

Statements

title
TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15671561
retrieved
20 September 2017
author name string
Yasuji Yamamoto
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15671561
retrieved
20 September 2017
Kazuhiko Yonekura
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15671561
retrieved
20 September 2017
Akihiro Hashimoto
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15671561
retrieved
20 September 2017
Konstanty Wierzba
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15671561
retrieved
20 September 2017
Tadafumi Terada
series ordinal
11
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15671561
retrieved
20 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40465362&oldid=2197587054"